References
- Seibold JR. Scleroderma. In: Harris ED, Budd RC, Firestein GS, et al., editors. Kelley’s textbook of rheumatology. 7th ed. Philadelphia (PA): Elsevier; 2005. p. 1279–1308.
- Mayes MD. Systemic sclerosis: clinical features. In: Klippel JH, Stone JH, Crafford LJ, et al. editors. Primer on the rheumatic diseases. 13th ed. New York (NY): Springer and Arthritis Foundation; 2008. p. 343–50.
- Mayes MD Jr, Lacey JV, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246–2255.
- European Organisation for Rare Diseases [Internet]. Rare diseases: understanding this public health priority. France: EURORDIS; [cited 2017 Jan 05]. Available from: http://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf
- Kole A, Faurisson F [Internet]. The voice of 12,000 patients: experiences and expectations of rare disease patients on diagnosis and care in Europe. EURORDIS; [cited 2017 Jan 05]. Available from: http://www.eurordis.org/IMG/pdf/voice_12000_patients/EURORDISCARE_FULLBOOKr.pdf
- Kwakkenbos L, Jewett LR, Baron M, et al. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open. 2013;3:e003563.
- Scleroderma Foundation [Internet]. Support groups. Danvers, MA: Scleroderma Foundation; [cited 2017 Jan 05]. Available from: http://www.scleroderma.org/site/PageServer?pagename=patients_supportgroups#.Vbec7RZvdFw
- Scleroderma Canada [Internet]. Find a support group; Ontario: Scleroderma Canada; [cited 2017 Jan 05]. Available from: http://www.scleroderma.ca/Support/Find-A-Support-Group.php
- Davison KP, Pennebaker JW, Dickerson SS. Who talks? The social psychology of illness support groups. Am Psychol. 2000;55:205.
- Aymé S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371:2048–2051.
- Barg FK, Gullatte MM. Cancer support groups: meeting the needs of African Americans with cancer. Semin Oncol Nurs. 2001;17:171–178.
- Delisle VC, Gumuchian ST, Peláez S, et al. Reasons for non-participation in scleroderma support groups. Clin Exp Rheumatol. 2016;34:56–62.
- Page BJ, Pietrzak DR, Lewis TF. Development of the group leader self-efficacy instrument. J Specialists Group Work. 2001;26:168–184.
- Zordan RD, Juraskova I, Butow PN, et al. Exploring the impact of training on the experience of Australian support group leaders: current practices and implications for research. Health Expect. 2010;13:427–440.
- Butow P, Ussher J, Kirsten L, et al. Sustaining leaders of cancer support groups: the role, needs, and difficulties of leaders. Soc Work Health Care. 2005;42:39–55.
- Kirsten L, Butow P, Price M, et al. Who helps the leaders? Difficulties experienced by cancer support group leaders. Support Care Cancer. 2006;14:770–778.